Navigation Links
GeoVax Labs, Inc. Comments on Discontinuance of Merck's HIV Vaccine Trial
Date:9/24/2007

ATLANTA, Sept. 24 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX)

On September 21, 2007, Merck & Co., Inc. announced their candidate AIDS vaccine failed to provide protection in a human study designed to test for efficacy.

In this Merck trial involving high risk volunteers, an equal number of people received either placebo or AIDS vaccine. The independent Data Safety Monitoring Board recommended that the trial be stopped because it was not reaching its efficacy endpoints.

Merck has stopped further vaccinations but will continue to follow volunteers in the trial. The Merck trial was being carried out in conjunction with the HIV Vaccine Trials Network (HVTN), a prestigious trial network funded by the US National Institutes of Health.

Don Hildebrand, GeoVax's President and CEO, commented, "We, along with the rest of the scientific community, are disappointed in the clinical failure of Merck's HIV vaccine trial. We all share the same goal of finding a safe and effective vaccine to address the devastation of the HIV/AIDS epidemic. We, however, would like to take this opportunity to highlight important differences between our vaccine technology and the technology used in the Merck trial."

GeoVax AIDS vaccines advancing in human trials represent a significantly different vaccine approach, vaccine composition and results to date than the Merck vaccine.

1) Prototypes for the GeoVax vaccines were selected from a series of trials in non-human primates for their ability to protect against the development of AIDS when vaccinated individuals were administered an AIDS causing virus. At each major step along the development pathway, GeoVax vaccines providing the best protection against AIDS were moved forward.

2) GeoVax AIDS vaccines demonstrated excellent protective results in non- human primate models, much better protective results than reported for Merck's vaccine in similar models. GeoVax AIDS vaccines pro
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
2. DOR BioPharma Announces Issuance of European Patent for Its Oral Multivalent Botulinum Toxin Vaccine BT-VACC
3. From Clinical Cancer Research: Rethinking Therapeutic Cancer Vaccine Trials
4. DOR BioPharma Announces Publication Describing Results of Its Multivalent Botulinum Toxin Vaccine BT-VACC
5. Vaccine Can Prevent Cervical Cancer and Precancerous Lesions
6. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
7. Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
8. HepaLifes PBS-1 Cells for Influenza Vaccine Production Prove Superior at International Conference
9. New Flu Vaccine from PepTcell Could Provide Immunity Against All Strains of Influenza Virus
10. Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure Reduction During Important Early Morning Period When Most Adverse Cardiovascular Events Occur
11. New Flu Vaccine From PepTcell Could Provide Immunity Against All Strains of Influenza Virus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... Mass. , May 17, 2013  Boston Scientific ... participate at the annual EuroPCR Scientific Program May 21-24 ... are pleased to present a particularly rich and diversified ... Keith Dawkins , M.D., global chief medical ... trials will be presented, including the NG PROMUS trial, ...
(Date:5/16/2013)... FRANCISCO , May 16, 2013  Nektar Therapeutics, (Nasdaq: ... Howard W. Robin , is scheduled to present ... New York at the Sheraton New York ... time. The presentation will be accessible via a ... Calendar section of the Nektar website: http://www.nektar.com . This ...
(Date:5/16/2013)... Calif. , May 16, 2013  Amgen (NASDAQ: ... Sciences Conference on Tuesday, May 21, 2013, at the Sheraton ... , beginning at 10:00 a.m. Eastern Daylight Time. ... president of Research and Development at Amgen, will present at ... from the Events Calendar on Amgen,s website, www.amgen.com , ...
Breaking Medicine Technology:Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 2Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 4Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 5Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 7Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 8Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City 2
... AMD patients, LOUISVILLE, Ky., Sept. 29 ... for the treatment,of age-related macular degeneration (AMD) announced ... shown early positive safety,results in its Phase I ... the complement activation cascade that could otherwise lead ...
... Foundation to improve healthcare,system in the Democratic Republic ... The Clinton Global,Initiative recognized BD (Becton, Dickinson ... medical technology company, for its commitment to the,Dikembe ... and,healthcare worker safety at the Biamba Marie Mutombo ...
Cached Medicine Technology:Potentia Pharmaceuticals Announces Positive Safety Data and Study Expansion in Phase I Trial for Lead Drug Candidate POT-4 2Clinton Global Initiative Announces BD's Commitment to Biamba Marie Mutombo Hospital 2Clinton Global Initiative Announces BD's Commitment to Biamba Marie Mutombo Hospital 3
(Date:5/19/2013)... have long recognized ginger as a great way to ... savory dishes; now, a study from researchers at Columbia ... may have properties that help asthma patients breathe more ... presented at the ATS 2013 International Conference. , Asthma ... tubes that carry air into and out of the ...
(Date:5/19/2013)... In partnership with the medical practice online ... launch of an SEO website for dentists. The purpose of ... Google. , http://www.e-dentists.com/ , A perk to the ... until they see results. Dentists can request the keywords they ... by JD Media Surge, LLC rank high for competitive keywords. ...
(Date:5/19/2013)... May 19, 2013 According to ... Analysis and Forecast (2013 – 2018): By Applications ... Industrial)); Technology (CCD, CMOS, Contact IS, Infrared, X-Ray) ... image sensor market was $8.00 billion in 2012 ... 2018, at an estimated CAGR of 3.84% from ...
(Date:5/19/2013)... York, New York (PRWEB) May 19, 2013 ... that a Case Management Conference was recently convened for ... a federal multidistrict litigation now underway in U.S. District ... posted on the Court’s website on May 14th, the ... It was also reported during the Conference that ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 Vegas Hotel ... is proud to announce the launch it's all new ... the MGM Grand on 5/19/2013. Consumers traveling to Las ... special pricing available on VegasHotelEscapes.com's website. Travelers will be ... beat any competitors price. , Vegas Hotel Escapes specializes ...
Breaking Medicine News(10 mins):Health News:Ginger compounds may be effective in treating asthma symptoms 2Health News:Effective New Dental SEO Solution Launched by E-dentists.com in Partnership with JD Media Surge, LLC 2Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 2Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 3Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 2Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 3
... access to health care and education hinder minorities ... services and often lead to delayed cancer diagnoses. ... geared toward African-Americans, researchers with the University of ... Centers for Healthy Hearts and Souls, a Pittsburgh-based ...
... for reconciling medications across the healthcare continuum and broaden ... ... SAN BRUNO, Calif., Oct. 29 First DataBank announced,today ... Base(TM), a computerized physician order entry,(CPOE)-ready drug database designed for ...
... Cardica, Inc.,(Nasdaq: CRDC ) today announced that it ... shares of its common stock for sale by,Cardica and ... a selling,stockholder in an underwritten public offering. Cardica will ... the selling stockholder. Cardica,expects to grant the underwriters a ...
... SDA Urge Proper, Effective In-School Hygiene and Cleaning ... Many news stories have,reported on cases of students ... methicillin-resistant staphylococcus aureus -- MRSA for,short. Now a ... the steps that communities can take to combat ...
... China, Oct. 29 /Xinhua-PRNewswire/ -- WuXi PharmaTech (NYSE:,WX), ... today that Dr. Ge Li, the company,s Chairman ... Entrepreneur Of The Year (EOY) China,2007 Award. This ... 10 other,elite entrepreneurs on October 26 in the ...
... treatment recommendations, , , MONDAY, Oct. 29 (HealthDay News) ... for pediatricians to spot and begin early treatment ... Academy of Pediatrics has released two new reports ... , "Pediatricians are the front line" in identifying ...
Cached Medicine News:Health News:Education program leads to lasting improvement of cancer knowledge in African-Americans 2Health News:HealthTek Software Solutions Licenses First DataBank's OrderView Med Knowledge Base(TM) to Streamline Medication Selection, Management and Reconciliation 2Health News:HealthTek Software Solutions Licenses First DataBank's OrderView Med Knowledge Base(TM) to Streamline Medication Selection, Management and Reconciliation 3Health News:HealthTek Software Solutions Licenses First DataBank's OrderView Med Knowledge Base(TM) to Streamline Medication Selection, Management and Reconciliation 4Health News:Cardica Announces Proposed Public Offering of Common Stock 2Health News:Cardica Announces Proposed Public Offering of Common Stock 3Health News:Cleaning Hands, Saving Lives: The Spread of Staph Can Be Stopped 2Health News:Cleaning Hands, Saving Lives: The Spread of Staph Can Be Stopped 3Health News:WuXi PharmaTech (NYSE: WX) CEO Honored with Ernst & Young Entrepreneur Of The Year China 2007 Award 2Health News:WuXi PharmaTech (NYSE: WX) CEO Honored with Ernst & Young Entrepreneur Of The Year China 2007 Award 3Health News:Pediatricians' Group Issues New Autism Guidelines 2Health News:Pediatricians' Group Issues New Autism Guidelines 3
Multipiece PMMA IOL - Sulcus Fixation....
Hydrophilic Acrylic Intraocular Lens (Refractive and Bifocal). Anterior Chamber Lens....
Raysoft Foldable Intraocular Lens....
HAPTIBAG Hydrophilic Acrylic Lens....
Medicine Products: